Summary

Summary

Contract Unique IdentifierDO1.SLCNTR.464235 
Contract referenceInst. Nac. de Cancer-2020-00685 
Contract description:MEDICAMENTOS ONCOLOGICOS-AM-0168-2020 
Goods 
Contract Start:
05/08/2020 10:00:00 ((UTC-04:00) Georgetown, La Paz, Manaus, San Juan)
 
Contract End:
05/11/2020 10:00:00 ((UTC-04:00) Georgetown, La Paz, Manaus, San Juan)
 
Legally Binding?
 
Contract StateModified 

Contracting Company Identification

Contracting Company Identification


Supplier Company Identification

Supplier Company Identification



Object Info

Object Info

DGCP-08-ProcesosExcepcion 
Inst. Nac. de Cancer-CCC-PEEX-2020-0030 
MEDICAMENTOS ONCOLOGICOS-AM-0168-2020 
MEDICAMENTOS ONCOLOGICOS-AM-0168-2020 
LOGISTICA 
MALLEN GUERRA COTIZACIÓN NO 004553_EXT_CP001 
GoodsDominicana 
20,605,764 Dominican Pesos 

Financial & Delivery Conditions

Financial & Delivery Conditions

Delivery optionsTransporte incluido 
Contract Start Date
05/08/2020 10:00:00 ((UTC-04:00) Georgetown, La Paz, Manaus, San Juan)
 
Contract End Date
05/11/2020 10:00:00 ((UTC-04:00) Georgetown, La Paz, Manaus, San Juan)
 
nstituto Nacional del Cáncer Rosa Emilia Sánchez Pérez de Tavares Av. Correa y Cidrón, Esq. Rafael A. Sánchez Ravelo, Zona Universitaria DO 

Payment Conditions

Payment Conditions

Payment Method 
Invoice Payment Deadline60 days 

Contract Comments

Contract Comments


 
 
 1 
DO1.PCCNTR.938019 ContractData Container
 1.1  
-
    
Total sin descuentosValor del descuentoTotal ITBISTotal Otros ImpuestosSubtotalTotal
19,103,514.000.000.000.0020,603,164.0020,605,764.00
    
ReferenciaCódigo UNSPSCCuenta presupuestariaDescripciónCantidadUnidadPrecio unitario estimadoPrecio unitarioImporte moneda orig. s/ITBIS% Desc.Descuento moneda originalMonto Gravado (Obras)% ITBISITBIS Moneda Original% Otros ImpuestosOtros impuestos moneda originalPrecio total estimadoValor del precio de respuesta
    
1
51111713 - Alemtuzumab
2.3.4.1.01BEVACIZUMAB 100 MG INY130UD24,80024,8003,224,000.000.000.000.003,224,000.003,224,000.00
    
2
51111713 - Alemtuzumab
2.3.4.1.01BEVACIZUMAB 400 MG INY72UD97,82797,8277,043,544.000.000.000.007,043,544.007,043,544.00
    
3
51111616 - Capecitabina
2.3.4.1.01CAPECITABINA 500 MG (XELODA)5,600UD174173.75973,000.000.000.000.00974,400.00973,000.00
    
4
51111718 - Valrubicina
2.3.4.1.01PERTUZUMAB 420 MG PERJETA8UD210,090210,0901,680,720.000.000.000.001,680,720.001,680,720.00
    
5
51111716 - Rituximab
2.3.4.1.01RITUXIMAB 1400/11.7ML INY60UD78,00078,0004,680,000.000.000.000.004,680,000.004,680,000.00
    
6
51111716 - Rituximab
2.3.4.1.01RITUXIMAB 100 MG 10 ML123UD13,50013,500830,250.000.000.000.001,660,500.001,660,500.00
    
7
51111716 - Rituximab
2.3.4.1.01RITUXIMAB 500 MG INY20UD67,00067,200672,000.000.000.000.001,340,000.001,344,000.00
 
Contract Document Template

Contract Document Template

DescriptionFile Name
Download
Download
Download
Download

Budget Settings

Budget Settings

Investment
Own resources
20,605,764.00 DOP
 DOP
AccountValueAnnual Availability
2.3.4.1.0120,605,764.00  DOP----View
Payment Calendar
IDDescriptionValueMonthYear
1  MEDICAMENTOS ONCOLOGICOS-AM-0168-202020,605,764.00  DOPSeptiembre2020
Certificate of Appropriation
YearCertificate CodeCertificate VersionCertificate ValueCertificate StateCertificate Link
20201120,605,764.00  DOP